Revelation Biosciences Inc (REVB : NASDAQ)
Common Stock
$0.47
USD
-0.02 (-3.18%)
Last updated: 2026-10-19
Follow REVB
REVB
Revelation Biosciences Inc
WealthAwesomePerformance
1 Day
+577.76%
1 Week
+324.05%
1 Month
+253.24%
YTD
+207.02%
Key Statistics
Market Cap
$1.93M
52W High
$38.64
52W Low
$3.08
P/E Ratio
0.11
50 Day MA
$0.94
200 Day MA
$1.31
Beta
-0.06
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/19/2026 | $0.50 | $0.51 | $0.44 | $0.47 | $3.29 | 43,486 |
| 10/16/2026 | $0.70 | $0.70 | $0.47 | $0.48 | $0.48 | 632,485 |
| 10/15/2026 | $0.74 | $0.78 | $0.73 | $0.76 | $0.76 | 20,644 |
| 10/14/2026 | $0.73 | $0.76 | $0.71 | $0.72 | $0.72 | 22,765 |
| 10/13/2026 | $0.76 | $0.77 | $0.73 | $0.73 | $0.73 | 26,827 |
| 10/12/2026 | $0.80 | $0.80 | $0.77 | $0.77 | $0.77 | 12,570 |
| 10/9/2026 | $0.77 | $0.82 | $0.75 | $0.76 | $0.76 | 24,800 |
| 10/8/2026 | $0.81 | $0.81 | $0.77 | $0.77 | $0.77 | 63,270 |
| 10/7/2026 | $0.76 | $0.84 | $0.76 | $0.83 | $0.83 | 50,265 |
| 10/6/2026 | $0.79 | $0.80 | $0.75 | $0.75 | $0.75 | 34,725 |
Analyst Price Targets
Based on 1 analyst covering REVB · as of Oct 5, 2026
Wall Street analysts forecast REVB stock price to rise 3682.2% over the next 12 months.
Consensus
Strong Buy5.00 / 5.00
Avg. Target
US$17.75
+3682.2% Upside
Current Price
US$0.47
Last close
Analyst Breakdown (1 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on REVB's historical volatility
30-Day Vol
579.5%
Annualized
90-Day Vol
346.4%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$3.93
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$3.49 | US$0.47 – US$25.75 |
| 60 trading days | US$3.70 | US$0.22 – US$62.55 |
| 90 trading days | US$3.93 | US$0.12 – US$125.34 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Revelation Biosciences Inc
Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health. The company's lead product candidate is lead product candidate Gemini, a proprietary formulation platform of phosphorylated hexaacyl disaccharide (PHAD), an established Toll-like receptor 4 (TLR) agonist that works by modulating and rebalancing a dysregulated inflammatory response. It also engages in the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed its name to Revelation Biosciences, Inc. in January 2022. Revelation Biosciences, Inc. was incorporated in 2019 and is based in San Diego, California.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-11.24M
- Profit Margin
- 0.00%
- ROE (TTM)
- -154.77%
- EPS (Diluted)
- 4.60
- Book Value
- 2.58
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About REVB.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| FRGT | Freight Technologies Inc | $1.47 | +97900.00% |
| GP | GreenPower Motor Company Inc | $1.46 | +11217.83% |
| MBRX | Moleculin Biotech Inc | $5.26 | +1775.89% |
| SLN | Silence Therapeutics PLC | $19.58 | +125.58% |
| SXTC | China SXT Pharmaceuticals Inc | $0.11 | +71.08% |
| AFJKR | Aimei Health Technology Co., Ltd Right | $0.14 | +64.47% |
| XHG | XChange TEC.INC | $3.20 | +60.00% |
| SOBR | Sobr Safe Inc | $0.07 | +39.81% |